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world of global politics, social and cultural pressures,Tales of Disease Eradication:
and financial realities.”The Extreme Edge of Public Health Through accounts of earlier eradication campaigns
as well as speculation on what lies ahead, the authors
explore the central question of how the global commu-
Global Disease Eradication: nity enters into a commitment to disease eradication.
The Race for the Last Child According to Needham and Canning (pg. 120), each
By Cynthia A. Needham and Richard Canning of the previous and current eradication programs have
Washington, D.C.: ASM Press (2003) hinged largely on the efforts of one individual who be-
196 pp. $39.95 came convinced of the possibility of success and
dragged the rest of the world along, sometimes kicking
and screaming. This conviction in turn arose from the
Do you think things are already complicated enough at discovery of “ideal” control tools—chloroquine and DDT
the subcellular level? Are you worn down by the aca- in the case of malaria, easy to administer vaccines for
demic competitiveness within your field and departmen- smallpox and polio, a simple water filtration technique
tal politics within your institution? Try stirring complexi- for guinea worm. The stories of how these individuals
ties such as geographic isolation, poverty, political moved their agendas forward to obtain the buy-in of
turmoil, international diplomacy, market forces and cor- world leaders then, of course, diverge in the particulars.
porate interests, plus the implications of bioterrorism, Yet the authors have used them to forge an instructive
overall lesson on the essentials for success. Thus, weinto the mix and you begin to appreciate the complica-
are shown how the global malaria eradication campaigntions that might await should your hard won research
of the 1950s and 1960s ultimately collapsed as a resultresults find their way through the lengthy development
of the inflexibility of its design, which failed to take socialpathway to reach fruition as a vaccine or drug. The new
and ecological differences into account or to incorpo-book, “Global Disease Eradication: The Race for the
rate a field research component that could have de-Last Child,” does a skillful job of conveying the scientific,
tected changes in the biology of the parasite and itslogistical, and moral dilemmas that must be faced in
mosquito vector. In juxtaposition, the authors’ focusorder to bring new disease control methods to the devel-
on the willingness of the leadership of the smallpoxoping world. It does so through a series of chapters
eradication campaign to incorporate innovations, suchdescribing unsuccessful (malaria), successful (small-
as the surveillance/containment strategy and the bifur-pox), and ongoing (polio and guinea worm) eradication
cated needle, into its design as a major reason for itsefforts. In this way, the authors manage to illustrate in
success. Likewise, innovations have played an impor-a highly readable manner many of the major challenges
tant role in the polio eradication campaign. These in-associated with the design and implementation of mas-
cluded the use of national immunization days as a waysive public health campaigns. Likewise, they manage to
to overcome both the inadequacy of local medical infra-illuminate the dedication, determination, and inventive-
structure and the shortcoming of vaccine instability, theness of those individuals committed to the humanitarian
development of new methods to respond to surveillancegoal of eradicating infectious diseases.
requirements, and the inclusion of a nongovernmentalAs described early in the book, “eradicating a dis-
organization (Rotary International) as a major fundingease—that is, stopping all transmission, pulling it out
partner. According to Needham and Canning, three con-by its roots—is quite different from controlling or elimi-
ditions are prerequisite to eradication: a method for in-nating it from a part of the world. Control and elimination
terrupting transmission; a means of detecting levels of
are important steps along the way, but they are not the
infection that will permit transmission; and a life cycle
same; they are not the ultimate public health goal—zero in which the human host is essential. Only when these
transmission—that defines eradication” (pg. 9). The requirements are met can one begin to contemplate an
World Health Organization (WHO) and its partners are eradication strategy. The “lessons learned” regarding
currently engaged in a number of elimination efforts, the likelihood of success for future eradication efforts
aimed at interrupting the transmission and/or reducing are summarized in four strategic areas: biological feasi-
the prevalence of diseases such as leprosy, filariasis, bility, financial resources, political will, and social
Chagas’ disease, measles, and trachoma, with the goal benefit.
of decreasing disability and rendering continued control Both within the disease-specific chapters and that on
more manageable by local health systems. As compli- the future of eradication efforts, the authors provide
cated as these efforts are, they do not approach the important insights into the logic that has been employed
long, hard slog required to achieve eradication. By fo- to obtain the often reluctant commitment of world lead-
cusing their discussion on the extreme edge of public ership. “Because eradication would cost so much, there
health, the idealistic goal of banishing a particular dis- was a need to convince governments and funding agen-
ease from the face of the earth, the authors cut right to cies that the end of malaria was more or less in sight.
the heart of the diversity of opinions and interests that They could be promised immediate and permanent ben-
influence decision making on the international scale. To efits in return for heavy, if short-term investments” (pg.
17). “Polio eradication was sold to the world in part likequote again, “ultimately…decisions are made in the real
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smallpox eradication, as a way to free up scarce health lars. For many reasons, one comes away from this book
understanding that eradication programs are not to becare resources” (pg. 109). Such arguments capitalize on
an inclination to save money while doing good. Indeed, entered into lightly, and that the rationale would be bet-
ter focused on life saving rather than cost saving. Thethe authors remind us of the estimates that smallpox
eradication saves approximately $1 billion annually in authors most clearly sum up their perspective at the
end of the chapter on the future of eradication, sayingthe costs previously associated with vaccination and
control, while potential global savings from polio eradi- that “it is clear, however, that given these circum-
stances—limited resources, unlimited need—eradicationcation are currently placed at $1.8 billion annually. To
the authors’ credit, they do not shy away from thought will have a future, and that it will continue to be risky
and thus controversial.”provoking issues, one of which is the reality of such
financial incentives. For example, within the chapters These stories of success and failure also illustrate that
the more things change, the more they stay the same.on smallpox and polio, they talk about the threat of
ongoing exposure. In so doing, they raise the issue that It was dismaying, yet perhaps perversely amusing, to
read the historical accounts of arguments and positionscost savings resulting from disease eradication may not
be as substantial as originally envisioned. Thus, they taken decades and even centuries ago that continue to
be voiced in conference rooms around the world today.discuss the fact that no decision has been reached
within the global community about destruction of known As mentioned above in the context of the malaria eradi-
cation campaign, the argument to deemphasize re-smallpox stocks, the possibility that live poliovirus could
reenter circulation accidentally due to laboratory release search in order to devote all available resources to cur-
rent control measures continues to play itself out withinor hidden human reservoirs, and the potential for bioter-
rorism using either virus. Recent events add emphasis to development agencies and public health initiatives. This
scenario was revisited in the recent past with tuberculo-the considerations mentioned in this book. Occasional
reports of paralysis resulting from vaccine-derived po- sis, where the research infrastructure had to be rebuilt
almost from scratch upon recognition of a resurgenceliovirus have prompted WHO to call for more research
and continued surveillance (Report of the interim meet- of disease due to multiple drug resistance and HIV/AIDS.
How many current programs for mass chemotherapy,ing of the Technical Consultative Group on the Global
Eradication of Poliomyelitis, WHO/V&B/03.04, 2003). Re- immunization, or vector control fail to incorporate long-
term monitoring components to assess adaptations inports of in vitro generation of pathogenic poliovirus from
cDNA constructed from sequence information (Cello, the biology or transmission patterns of the pathogen
that may influence the future course of infection, all inScience 297:1016-8, 2002), and of genetic alteration of
a smallpox-related mouse virus to overcome immunity the name of cost effectiveness? The merits of vertical
(targeted) versus horizontal (general) approaches to(Jackson, J. Virol. 75:1205-10, 2001) have increased
awareness of additional possibilities by which infection public health, another cost effectiveness controversy
that continues to be raised in disease control debates,might be reintroduced. With the horrific realization of
our vulnerability that resulted from terrorist activities in are likewise well described and compared in the chapter
on polio eradication. The discussions of the late 1950’s2001, came recognition of the difficulties involved in
preparing ourselves for the future. One such difficulty leading up to the smallpox eradication campaign are
also of extreme relevance today, as the authors contrastis the fact that industry generally does not continue
manufacturing products for which there is no market. the negative opinions of nations where the disease had
already been eliminated with those who still believedThus, with the banning of DDT for environmental reasons
DDT production facilities shut down (pg. 29). With the “when it came to infectious diseases, the world was
fairly small” (page 52). What a surprise the U.S. anderadication of smallpox, the vaccine market likewise
disappeared (pg. 122), requiring a sizeable influx of gov- other developed countries could have avoided over the
last decade, due to so-called emerging and reemergingernment biodefense funding recently in an effort to rein-
vigorate production and reinstate the vaccine delivery infectious diseases, had this perspective been remem-
bered! Descriptions of wavering public interest in immu-infrastructure in this country. Therefore, should the need
for surveillance and protection against each eradicated nization similarly provoke a feeling of “deja vu.” Thus,
we are reminded that in the late 19th century “surprisingdisease prove ongoing, the expected resource savings
resulting from eradication may be more difficult to sell numbers of people opposed vaccination, and small pox
remains a dangerous presence” and “as the diseaseas an incentive in the future. While the authors raise
the dilemma posed by disease eradication, in terms of receded, people began to take it less seriously” (page
49). Does this not call to mind the recent outbreaks ofincreasing the terrorist potential of the disease agent,
they cite the opinion of eradication campaigners, such measles and pertussis in the U.S. and other industrial-
ized countries due, at least in part, to a failure on theas Walter Dowdle, former deputy director of CDC: “Do
we ensure that the disease continues in poverty stricken part of parents to accept available vaccination for
their children?countries so that rich countries are not threatened by
bioterrorism? …It’s ridiculous; that option is simply not Whereas I found this book praiseworthy for managing
to touch on so many of the important and contentiousviable” (page 71). Even in the absence of such concerns,
the ultimate costs of eradication can be unpredictable. issues associated with multinational efforts in general
and eradication programs in particular, it does have aThis is illustrated by the problems being experienced in
the final stages of the current polio campaign, where a few weak points. While the history of each program is
told in an enjoyable as well as informative way, therecent outbreak in Nigeria has spread to neighboring
countries, requiring a new mass immunization campaign transition between chapters is interrupted by sections
describing the pathogens themselves. One wondersin that area at the cost of unanticipated millions of dol-
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whether this lack of integration was the product of two
authors who could not find a way to make their contribu-
tions mesh or an attempt to make the science less nec-
essary for those readers more interested in the history.
Likewise, there is an epilogue that consists of individual
consultations with various “voices from the eradication
campaigns.” While useful for expanding on the personal
recollections sprinkled throughout the historical ac-
counts, this piece also feels as if it may have been tacked
on at the end because the authors had gone to the effort
of conducting interviews and didn’t want their work
wasted. Last, but not least from a parasitologist’s per-
spective, was the error of calling protozoan Plasmodium
parasites multicellular (page 72). Nonetheless, the book
is a worthwhile read for those interested in how their own
research might someday integrate with public health.
As there is a growing call for increased assimilation
between biomedical and public health training in this
country (Who Will Keep the Public Healthy? Educating
Public Health Professionals for the 21st Century, National
Academy of Sciences, 2003), this book might be a good
tool for provoking that interest among students.
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